Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients

Basit Öğe Kaydı
dc.contributor.authorSahin, Fahri
dc.contributor.authorSaydam, Güray
dc.contributor.authorComert, Melda
dc.contributor.authorUz, Burak
dc.contributor.authorYavuz, Akif Selim
dc.contributor.authorTuran, Esra
dc.contributor.authorYonal, Ipek
dc.contributor.authorAtay, Hilmi
dc.contributor.authorKeltikli, Engin
dc.contributor.authorTurgut, Mehmet
dc.contributor.authorPehlivan, Mustafa
dc.contributor.authorAkay, Meltem Olga
dc.contributor.authorGurkan, Emel
dc.contributor.authorPaydas, Semra
dc.contributor.authorKahraman, Selda
dc.contributor.authorDemirkan, Fatih
dc.contributor.authorKirkizlar, Onur
dc.contributor.authorAkpinar, Seval
dc.contributor.authorPamuk, Gulsum Emel
dc.contributor.authorDemir, Muzaffer
dc.contributor.authorOzbas, Hasan Mucahit
dc.contributor.authorSonmez, Mehmet
dc.contributor.authorGulturk, Mine
dc.contributor.authorSalihoglu, Ayse
dc.contributor.authorEskazan, Ahmet Emre
dc.contributor.authorAr, Cem
dc.contributor.authorSahin, Handan Haydaroglu
dc.contributor.authorOngoren, Seniz
dc.contributor.authorBaslar, Zafer
dc.contributor.authorAydin, Yildiz
dc.contributor.authorYenere, Mustafa Nuri
dc.contributor.authorTuzuner, Nukhet
dc.contributor.authorFerhanoglu, Burhan
dc.contributor.authorHaznedaroglu, Ibrahim C.
dc.contributor.authorIlhan, Osman
dc.contributor.authorSoysal, Teoman
dc.date.accessioned2019-10-27T22:07:05Z
dc.date.available2019-10-27T22:07:05Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description.abstractObjective: here have been tremendous changes in treatment and follow-up of patients with chronic myeloid leukemia (CML) in the last decade. Especially, regular publication and updating of NCCN and ELN guidelines have provided enermous rationale and base for close monitorization of patients with CML. But, it is stil needed to have registry results retrospectively to evaluate daily CML practices. Materials and Methods: In this article, we have evaluated 1133 patients' results with CML in terms of demographical features, disease status, response, resistance and use of second-generation TKIs. Results: The response rate has been found relatively high in comparison with previously published articles, and we detected that there was a lack of appropriate and adequate molecular response assessment. Conclusion: We concluded that we need to improve registry systems and increase the availability of molecular response assessment to provide high-quality patient care.en_US
dc.identifier.doi10.4274/tjh.2013.0151
dc.identifier.endpage358en_US
dc.identifier.issn1300-7777
dc.identifier.issn1308-5263
dc.identifier.issue4en_US
dc.identifier.pmid24385824en_US
dc.identifier.startpage351en_US
dc.identifier.urihttps://doi.org/10.4274/tjh.2013.0151
dc.identifier.urihttps://hdl.handle.net/11454/48948
dc.identifier.volume30en_US
dc.identifier.wosWOS:000331341700002en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofTurkish Journal of Hematologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChronic myeloid leukemiaen_US
dc.subjectRegistryen_US
dc.subjectResponseen_US
dc.titleTurkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu